Doxifluridine: Previous Experience and new Developments in the Treatment of Colorectal Cancer

Abele R. , Alberto P. , Kaplan S. , Siegenthaler P. , Cavalli F. : Phase II study of doxifluridine in advanced colorectal adenocarcinoma. J. Clin. Oncol., 12: 750–754, 1983.

Amstrong R.D. , Diasio R.B. : Metabolism and effets of a new fluorouracil derivative: 5-deoxy-5-fluorouridine. Eur. J. Cancer, 16: 427–432, 1979.

Bajetta E. , Colleoni M. , Di Bartolomeo M. , Buzzoni R. , Bozzetti F. , Doci R. , Somma L. , Cappuzzo F. , Gallo Stampino C. , Guenzi A. , Balant L.P. , Zilembo N. , Di Leo A. : Doxifluridine and leucovorin: an oral treatment combination in advanced colorectal cancer. J. Clin. Oncol., 13: 2613–2619, 1995.

Bajetta E. , Colleoni M. , Rosso R. , Sobrero A. , Hofmann V. , Ryssel H.J. , Hartmann D. , Holdener E. , Amadori D. , Cornelia G. , Marangolo M. , Scanni S. , Lorusso V. , Calabresi F. , Bonsignori M. , Crivellari D. , Pasquini E. , Bruzzi P. , Criscuolo D. : Prospective randomized trial comparing fluorouracil vs doxifluridine for the tretament of advanced colorectal cancer, Eur. J. Cancer, 12: 1658–1663, 1993.

Bajetta E. , Di Bartolomeo M. , Somma L. , Moreschi M. , Cornelia G. , Turci D. , Gebbia V. , Scanni A. , Bordogna G. , Gallo Stampino C. : Randomized Phase II non comparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal cancer. Cancer, 78: 2087–93, 1996.

Bajetta E. , Di Bartolomeo M. , Somma L. , Del Vecchio M. , Artale S. , Zumino F. , Bignami P. , Magnani E. , Buzzoni R. : Doxifluridine in colorectal cancer patients resistant to fluorouracil (5-FU) containing regimens. Eur. J. Cancer, in press.

Cook A.F. , Holman M.J. , Kramer M.J. , Trown P.W. : Fluorinated pyrimidine nucleosides 3. Synthesis and antitumor activity of a series of 5-deoxy-5-fluoropyrimidine nucleosides, J. Med. Chem., 22: 1330–1335, 1979.

Herteloup P. , Armand I.P. , Cappelaere P. , Metz R. , Kerbrat P. , Keiling R. , Fumoleau P. , Fargeot P. , Schraub S. , Bastit P. , Caudry M. , Cauchie C. , Nasca S. , Pommatau E. , Hayat M. , Chollet P. , Nasca S. , Pommatua E. , Hayat M. , Chollet P. , Renard J. , Van Glabbeke M. , Mathè G. : Phase II clinical evaluation of doxifluridine. Cancer Treat. Rep., 70: 731–737, 1986.

Ishitsuka H. , Miwa M. , Takemoto K. : Role of uridine phosphorylase for antitumor activity of 5'deoxy-5-fluorouracil in tumor bearing mice and rats. Gann, 71: 112–123, 1980.